Kolibri
Medical device
A true pioneer in regard to ease of use, the Kolibri Nebulizer evolves inhalation therapy. Simplified radically and technologically developed, it only has 4 simple parts, making handling extremely easy. Also, users can take it everywhere in their pocket, similar to a common asthma spray. In use, the Kolibri generates data about inhalation technique and adherence, then transfers these directly to Pulmotree Connect, a digital eco-system. Here, patients get feedback and support and gain full insight into the treatment process. These insights can feed into clinical trials and improve the effectiveness of inhalation treatments.
Date of Launch
2022
Development Time
25 - 36 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumer / User